DOES THE ADVANCED GLYCATION END PRODUCTS FOOD INTAKE INFLUENCE MORTALITY IN DIALYSIS PATIENTS?

  • Lada Trajcheska University Clinic of Nephrology Skopje
  • Stefan Arsov Institute of Epidemiology, Biostatistics and Medical Informatics, Skopje, Macedonia
  • Pavlina Dzekova Vidimliski University Clinic of Nephrology – Skopje, Macedonia
  • Gjulsen Selim University Clinic of Nephrology – Skopje, Macedonia
  • Irena Rambabova Busletik University Clinic of Nephrology – Skopje, Macedonia
  • Aleksandar Sikole University Clinic of Nephrology – Skopje, Macedonia

Abstract

Introduction:Advanced glycation end products (AGEs) are considered as uremic toxins and contribute to cardiovascular complications in HD patients.Consumption of specific foods is associated with increased AGEs.In this study we investigated the AGE food consumption as a potential risk of mortality in dialysis patients.Methods:A study group of 150 dialysis patients were asked to fill in a 7-day diet questionnaire where from the data on protein, calorie and AGEs daily food intakes were extrapolated.Patients were followed for 36 months. Kaplan-Meier survival curves were applied to estimate difference in survival in patients with low(below median intake), or high (above median intake) of AGEs. The median CRP level was obtained for survival correction by inflammation. Results:The mean age of study participants was 55 years and 62% of them were men. The average amount of daily intake of AGEs was 9.4 ±4.0 MU/24 hours. The average daily protein and calories intake were within current recommendations. The median level of daily AGEs intake was 8.9 MU/day.When patients were stratified by AGEs rich or poor diet and inflammatory state, no difference for survival was found in all groups. Patients with high inflammation did not differ in survival in relation to rich or poor AGEs diet (p=0.614). In patients with low CRP better survival had patients consuming more AGEs, but the difference was not statistically significant (p= 0.167).Conclusion:Inflammation strongly impacts survival of dialysis patients. Rich AGEs food diet was not found to be at risk of mortality. Traditional diet explains better outcomes in dialysis patients.

References

1. Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003;63(5):1934–43
2. Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC, Thorpe SR, Baynes JW, Navis G, Gans RO, et al. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol. 2005;16(12):3687–93.
3. Goldberg T, Cai W, Peppa M, Dardaine V, Baliga BS, Uribarri J, Vlassara H. Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc. 2004;104 (8):1287–91.
4. Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, Yong A, Striker GE, Vlassara H. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010;110(6):911–6.
5. Arsov S, Trajceska L, van Oeveren W, Smit AJ, Dzekova P, Stegmayr B, Sikole A, Rakhorst G, Graaff R. The influence of body mass index on the accumulation of advanced glycation end products in hemodialysis patients. Eur J Clin Nutr. 2015; 69(3):410
6. Bonanni, A., Mannucci, I., Verzola, D. et al. Protein-energy wasting and mortality in chronic kidney disease. Int J Environ Res Public Health. 2011; 8: 1631–1654
7. The United States Department of Agriculture. Nutritive Value of Foods. http://www.ars.usda.gov/SP2UserFiles/Place/12354500/Data/hg72/hg72_2002.pdf. 2002
8. Selim G, Stojceva-Taneva O, Zafirovska K, Sikole A, Gelev S, Dzekova P, et al. Inflammation predicts all-cause and cardiovascular mortality in haemodialysis patients. Prilozi. 2006;27:133–44.
9. Beberashvili I, Sinuani I, Azar A, Yasur H, Shapiro G, Feldman L, et al. IL-6 levels, nutritional status, and mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol. 2011;6:2253–63.
10. Heidari B. C-reactive protein and other markers of inflammation in hemodialysis patients. Caspian J Intern Med. 2013; 4:611–6.
11. Weng, C. H., Hu, C. C., Yen, T. H. & Huang, W. H. Association between ambient carbon monoxide and secondary hyperparathyroidism in nondiabetic patients undergoing peritoneal dialysis. Ther Clin Risk Manag 11, 1401–1408, 10.2147/TCRM.S91475 (2015).
12. National Kidney, F. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am J Kidney Dis 66, 884–930
13. Weng CH, Hu CC, Yen TH, Hsu CW, Huang WH. Nutritional predictors of mortality in long term hemodialysis patients. Sci Rep. 2016; 6: 35639. doi: 10.1038/srep35639.
Published
2018-12-27
How to Cite
TRAJCHESKA, Lada et al. DOES THE ADVANCED GLYCATION END PRODUCTS FOOD INTAKE INFLUENCE MORTALITY IN DIALYSIS PATIENTS?. Journal of Morphological Sciences, [S.l.], v. 1, n. 2, p. 29-33, dec. 2018. ISSN 2545-4706. Available at: <http://jms.mk/jms/article/view/33>. Date accessed: 19 july 2019.
Section
Articles